Company chart and information is provided by TradingView based on 15-minute-delayed data.
KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates through the region of United States.
| Website: | www.kalvista.com |
| Email: | ir@kalvista.com |
| Main Phone: | +1 857 999-0075 |
| Address: | 55 Cambridge Parkway |
| Address 2: | Suite 901 East |
| State: | MA |
| City / Town: | Cambridge |
| Country: | US |
| Postal Code: | 02142 |
| Exchange: | NSD |
| CEO: | Thomas Andrew Crockett |
| Employees: | 56 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
